Donate
(Newsweek) Millions of Americans struggling with depression could benefit from the active ingredient in magic mushrooms, new research suggests. However, approval of such treatments will depend on the U.S. Food and Drug Administration (FDA).
In this Learning Lab, Dr. Tracy Balboni and Dr. Michael Balboni will discuss the most recent research showing how spirituality is important in patient care and holds the promise of reinvigorating how flourishing communities care for the sick.
Vail Health Foundation invites you to a short lecture by Dr. Raison and Giulio Tononi, a world-renown researcher focused on consciousness, who will present an overview of the center’s first study areas in psilocybin, psychedelics, and heat therapy as treatments for depression.